In this study we depleted endogenous MEK1 in CRC cells to investigate whether MEK1 is indispensable for anti-tumor activity of PRIMA-1Met since many small molecules that targeting the main target have off targets [35, 36]. The gene discussed is MAP2K1; the disease is neoplasm.